Thailand Hub of Talents in Cancer Immunotherapy (TTCI Thailand)

หัวข้อวิจัย

Thailand Hub of Talents in Cancer Immunotherapy (TTCI Thailand)หัวข้อวิจัย

Cancer Clinical Trials: Industry-Sponsored and Investigator-Initiated Phase II–III Studies in Solid Tumours

Research Topics Cancer Clinical Trials: Industry-Sponsored and Investigator-Initiated Phase II–III Studies in Solid Tumours Researchers Siwat Sakdejayont (Sub-Investigator) Institute Chulabhorn Hospital, Chulabhorn Royal Academy Funding Pharmaceutical industry Timeline 2024–present...
อ่านต่อไป

A Phase 1b clinical trial to evaluate the safety and efficacy of BCMA-targeted CAR T-cell therapy in Thai patients with relapsed or refractory multiple myeloma.

Research Topics Antitumor activities of chimeric antigen receptor T cells targeting Mucin-1 with self-released anti-PD-1 IgG antibody Researchers Dr.Koramit Suppipat Institute Multicenter Clinical Trials Funding PMU-C Timeline 2026-2028 Facebook...
อ่านต่อไป

Development of CAR T-cell Products for the Treatment of Hematologic Malignancies to Enhance the Competitiveness of Thailand’s Advanced Therapy Medicinal Products (ATMP) Industry (Phase 1)

Research Topics Development of CAR T-cell Products for the Treatment of Hematologic Malignancies to Enhance the Competitiveness of Thailand’s Advanced Therapy Medicinal Products (ATMP) Industry (Phase 1) Researchers Koramit...
อ่านต่อไป

Safety/Phase I study of PiggyBac transposon mediated Chimeric Antigen Receptor T cells targeting CD-19 in Thai patients with refractory systemic lupus Erythematosus

Research Topics Safety/Phase I study of PiggyBac transposon mediated Chimeric Antigen Receptor T cells targeting CD-19 in Thai patients with refractory systemic lupus Erythematosus Researchers Wannagam Kijthanamongkolchai Institute Faculty...
อ่านต่อไป

Expanding Horizons in Immunotherapy: Integrating Advanced Cell Engineering, Reprogramming, and Adjunct Therapies for Cancer and inflammatory-mediated diseases

Research Topics Expanding Horizons in Immunotherapy: Integrating Advanced Cell Engineering, Reprogramming, and Adjunct Therapies for Cancer and inflammatory-mediated diseases Researchers Prof.Nattiya Hirankarn and TTCI team Institute Faculty of Medicine,...
อ่านต่อไป

Clinical resolution of autoimmune choroiditis and multiorgan involvement of refractory systemic lupus erythematosus patient treated with CD19CAR-T incorporated CD28/CD40 signaling molecules

Research Topics Clinical resolution of autoimmune choroiditis and multiorgan involvement of refractory systemic lupus erythematosus patient treated with CD19CAR-T incorporated CD28/CD40 signaling molecules Researchers Jakrawadee Julamanee,Panarat Noiperm,Watsamon Uraiwan,Porntip Intapiboon,Parichat...
อ่านต่อไป